| Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV (NCT03291158) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2018-04-01 |
| Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects (NCT02073812) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2014-02-01 |
| The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency (NCT02020434) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2014-01-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects (NCT01897779) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2013-07-01 |
| Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination (NCT01772836) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2013-03-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects (NCT01751269) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-12-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects (NCT01702649) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-08-01 |